Question 1

Am I eligible for this trial based on my treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) clinical trial (NCT05519449). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of JANX007 compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) clinical trial (NCT05519449). Contact the study team or your healthcare provider for specific answers.

Question 3

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) clinical trial (NCT05519449). Contact the study team or your healthcare provider for specific answers.

Question 4

What does the treatment cycle look like, and how long will I be in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) clinical trial (NCT05519449). Contact the study team or your healthcare provider for specific answers.

Question 5

Can you explain how this trial might fit with my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) clinical trial (NCT05519449). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I expect during the trial in terms of tests and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) clinical trial (NCT05519449). Contact the study team or your healthcare provider for specific answers.

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

What this study is about

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

What this study is about